1-(5-azido-2,5-dideoxy-α-D-erythro-pentofuranosyl)thymine | 158603-60-2

• 分子结构分类: 有机化合物 - 核苷、核苷酸和类似物 - 2 '，5'-二脱氧核苷
• 英文名称: 1-(5-azido-2,5-dideoxy-α-D-erythro-pentofuranosyl)thymine
• 英文别名: 5'-azido-5’-deoxy-α-thymidine；5'-azido-5'-deoxy-α-thymidine；1-[(2S,4S,5R)-5-(azidomethyl)-4-hydroxy-tetrahydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione；1-[(2S,4S,5R)-5-(azidomethyl)-4-hydroxyoxolan-2-yl]-5-methylpyrimidine-2,4-dione
• CAS: 158603-60-2
• 化学式: C₁₀H₁₃N₅O₄
• 分子量: 267.244
• InChiKey: GKEHVJFBPNPCKI-RNJXMRFFSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.1
• 重原子数：
  19
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.6
• 拓扑面积：
  93.2
• 氢给体数：
  2
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  1-(5-azido-2,5-dideoxy-α-D-erythro-pentofuranosyl)thymine 在 palladium 10% on activated carbon 作用下， 以 甲醇 为溶剂， 反应 3.0h， 生成 5'-amino-5'-deoxy-α-thymidine
  参考文献：
  名称：

  α-胸苷抑制剂与恶性疟原虫胸苷酸激酶的相互作用

  摘要：

  恶性疟原虫胸苷酸激酶（PfTMK）是嘧啶核苷酸从头生物合成途径中的关键酶。N-（5'-脱氧-α-胸苷-5'-基）-N '-[4-（2-氯苄氧基）苯基]脲被开发为PfTMK的抑制剂，并且据报道是有效的P抑制剂。 EC 50为28 nM的恶性疟原虫的生长[Cui，H.，et al。（2012）J.Med。化学 55，10948-10957]。使用该化合物作为支架，开发了许多衍生物，并与原始化合物一起通过其酶抑制（K i）和结合亲和力（K D）进行了表征。）。此外，通过诱变和对接模拟的组合研究了合成化合物的结合位点。尽管已报道的化合物被证明在抑制寄生虫生长方面非常有效，但我们观察到的结合亲和力和对PfTMK的抑制作用均比据报道的EC 50预期的要低得多。这表明使用该支架作为有效的PfTMK抑制剂将需要进行显着的结构优化，并且寄生虫生长的抑制是由于脱靶效应引起的。

  DOI：

  10.1021/acs.biochem.8b00162
• 作为产物：
  描述：

  O,O-二(三甲基甲硅烷基)胸苷 在 三氟甲磺酸三甲基硅酯 、 氨 作用下， 以 甲醇 、 乙腈 为溶剂， 反应 40.5h， 生成 1-(5-azido-2,5-dideoxy-α-D-erythro-pentofuranosyl)thymine
  参考文献：
  名称：

  5'-Azido and 5'-Fluoro alpha-Nucleosides as Analogues of AZT and FLT.

  摘要：

  5-Azido-2,5-dideoxy-beta-D-erythro-pentofuranosyl nucleosides 10 and their corresponding alpha-anomers 11 have been synthesized by condensation of methyl 3-O-acetyl-5-azido-2,5-dideoxy-beta-D-erythro-pentofuranoside (7) with silylated nucleobases followed by deprotection with methanolic ammonia. Reaction of silylated thymine (19) with methyl 2,3-di-O-benzoyl-5-deoxy-5-fluoro-D-arabino-pentofuranoside (15) and methyl 5-azido-2,3-di-O-benzoyl-5-deoxy-alpha-D-arabino-pentofuranoside (17alpha) afforded a mixture of the alpha-nucleosides 20 and the acyclo nucleosides 5-fluoro- and 5-azido-2,3-O-dibenzoyl-5-deoxy-1-O-methyl-1-(thymin-1-yl)-D-arabinitol (22). Compounds 20 and 22 were deprotected with methanolic ammonia to give the acyclic nucleosides 21 and 23, respectively. The new nucleosides were inactive against HSV-1 and HIV-1.

  DOI：

  10.3891/acta.chem.scand.48-0215

文献信息

• Synthesis and Evaluation of α-Thymidine Analogues as Novel Antimalarials
  作者：Huaqing Cui、Juana Carrero-Lérida、Ana P. G. Silva、Jean L. Whittingham、James A. Brannigan、Luis M. Ruiz-Pérez、Kevin D. Read、Keith S. Wilson、Dolores González-Pacanowska、Ian H. Gilbert

  DOI：10.1021/jm301328h

  日期：2012.12.27

  Plasmodium falciparum thymidylate kinase (PfTMPK) is a key enzyme in pyrimidine nucleotide biosynthesis. 3-Trifluoromethyl-4-chloro-phenyl-urea-α-thymidine has been reported as an inhibitor of Mycobacterium tuberculosis TMPK (MtTMPK). Starting from this point, we designed, synthesized and evaluated a number of thymidine analogues as antimalarials. Both 5′-urea-α- and β-thymidine derivatives were moderate

  恶性疟原虫胸苷酸激酶 ( Pf TMPK) 是嘧啶核苷酸生物合成的关键酶。3-Trifluoromethyl-4-chloro-phenyl-urea-α-thymidine 已被报道为结核分枝杆菌TMPK ( Mt TMPK)的抑制剂。从这一点出发，我们设计、合成并评估了许多作为抗疟药的胸苷类似物。5'-尿素-α-和β-胸苷衍生物都是Pf TMPK 的中度抑制剂，并且还显示出对寄生虫生长的中度抑制。几种酶-抑制剂复合物的结构为改进抑制剂设计提供了基础。然而，我们发现某些 5'-尿素-α-胸苷类似物具有抗疟活性，其中PfTMPK 不是主要的作用方式。该系列的优化产生了具有有效抗疟活性的化合物（EC 50 = 28 nM；CC 50 = 29 μM）。
• [EN] DERIVATIVES OF PHENYL (THIO) UREA DEOXYTHYMIDINE AND USE THEREOF AS ANTIMALARIALS<br/>[FR] DÉRIVÉS DE PHÉNYL(THIO)URÉEDÉSOXYTHYMIDINE ET LEUR UTILISATION COMME ANTIPALUDIQUES
  申请人：UNIV DUNDEE

  公开号：WO2013014445A1

  公开（公告）日：2013-01-31

  Deoxythymidine derivatives according to formula (I) are disclosed. wherein: X may be O or S; and R1, R2, R3, R4 and R5 may each be independently selected from H, halo, C1-C6 alkyl, C1-C6 haloalkyl, nitro, phenyl, heteroaryl, substituted heteroaryl wherein the substituents may be C1-C6 alkyl or C1-C6 haloalkyl, benzyl, -CH2OAr, -OR6 and six-membered ring heterocyclic groups containing 1 or more O and/or N heteroatoms wherein any N heteroatom may be C1-C6 alkyl-substituted; and R6 may be selected from C1-C6 alkyl, phenyl, six-membered ring heterocyclic groups containing at least one O heteroatom, benzyl and substituted benzyl wherein the substituents may be halo, C1-C6 alkyl or C1-C6 alkoxy; R7 may be H or C1-C6 alkyl; and the stereochemistry of the bond depicted as 〰 is either α or β. Such derivatives have shown good inhibitory activity against malaria-causing parasites, e.g. Plasmodium falciparum, but have shown low levels of toxicity to human cells.

  根据公式（I），披露了脱氧胸苷衍生物。其中：X可以是O或S；R1、R2、R3、R4和R5可以分别独立地选择自H、卤素、C1-C6烷基、C1-C6卤代烷基、硝基、苯基、杂环芳基、取代的杂环芳基，其中取代基可以是C1-C6烷基或C1-C6卤代烷基、苄基、-CH2OAr、-OR6和含有1个或多个O和/或N杂原子的六元环杂环基团，其中任何N杂原子可以是C1-C6烷基取代的；R6可以选择自C1-C6烷基、苯基、含有至少一个O杂原子的六元环杂环基团、苄基和取代的苄基，其中取代基可以是卤素、C1-C6烷基或C1-C6烷氧基；R7可以是H或C1-C6烷基；而所示键的立体化学为α或β。这些衍生物已显示出对引起疟疾的寄生虫，如疟原虫（Plasmodium falciparum），具有良好的抑制活性，但对人类细胞的毒性水平较低。
• Synthesis and inhibitory activity of thymidine analogues targeting Mycobacterium tuberculosis thymidine monophosphate kinase
  作者：Sara Van Poecke、Hélène Munier-Lehmann、Olivier Helynck、Matheus Froeyen、Serge Van Calenbergh

  DOI：10.1016/j.bmc.2011.10.021

  日期：2011.12

  We report on Mycobacterium tuberculosis thymidine monophosphate kinase (TMPKmt) inhibitory activities of a series of new 3'- and 5'-modified thymidine analogues including alpha- and beta-derivatives. In addition, several analogues were synthesized in which the 4-oxygen was replaced by a more lipophilic sulfur atom to probe the influence of this modification on TMPKmt inhibitory activity. Several compounds showed an inhibitory potency in the low micromolar range, with the 5'-arylthiourea 4-thio-alpha-thymidine analogue being the most active one (K(i) = 0.17 mu M). This compound was capable of inhibiting mycobacteria growth at a concentration of 25 mu g/mL. (C) 2011 Elsevier Ltd. All rights reserved.
• Rational Design of 5‘-Thiourea-Substituted α-Thymidine Analogues as Thymidine Monophosphate Kinase Inhibitors Capable of Inhibiting Mycobacterial Growth
  作者：Ineke Van Daele、Hélène Munier-Lehmann、Matheus Froeyen、Jan Balzarini、Serge Van Calenbergh

  DOI：10.1021/jm0706158

  日期：2007.11.1

  Recently, thymidine monophosphate kinase (TMPK) emerged as an attractive target for developing inhibitors of Mycobacterium tuberculosis growth. The elucidation of the X-ray structure of TMPK of M. tuberculosis (TMPKmt), as well as the structure of an earlier serendipitously discovered dimeric thymidine inhibitor, laid the foundation for the design of potent and selective TMPKmt inhibitors reported here. Several hits identified within a series of 3'-C-branched thiourea-substituted P-thymidine derivatives inspired us to construct a set of 5'-thiourea-substituted a-thymidine derivatives characterized by a similar relative orientation of the thymine and arylthiourea moieties. (x-Thymidine derivative 15, featuring a (3-trifluoromethyl-4-chlorophenyl)thiourea moiety, has a K-i of 0.6 mu M and a selectivity index of 600 versus human TMPK. Moreover, it represents the first TMPK inhibitor showing good inhibitory activity on growing M. bovis (MIC99 = 20 mu g/mL) and M. tuberculosis (MIC50 = 6.25 mu g/mL) strains.
• 5'-Azido and 5'-Fluoro alpha-Nucleosides as Analogues of AZT and FLT.
  作者：Lone Schmidt、Erik B. Pedersen、Claus Nielsen、Chavdar B. Ivanov、Ralitza Atanasova、Anna Napoli、Giovanni Sindona、Dagfinn W. Aksnes、George W. Francis

  DOI：10.3891/acta.chem.scand.48-0215

  日期：——

  5-Azido-2,5-dideoxy-beta-D-erythro-pentofuranosyl nucleosides 10 and their corresponding alpha-anomers 11 have been synthesized by condensation of methyl 3-O-acetyl-5-azido-2,5-dideoxy-beta-D-erythro-pentofuranoside (7) with silylated nucleobases followed by deprotection with methanolic ammonia. Reaction of silylated thymine (19) with methyl 2,3-di-O-benzoyl-5-deoxy-5-fluoro-D-arabino-pentofuranoside (15) and methyl 5-azido-2,3-di-O-benzoyl-5-deoxy-alpha-D-arabino-pentofuranoside (17alpha) afforded a mixture of the alpha-nucleosides 20 and the acyclo nucleosides 5-fluoro- and 5-azido-2,3-O-dibenzoyl-5-deoxy-1-O-methyl-1-(thymin-1-yl)-D-arabinitol (22). Compounds 20 and 22 were deprotected with methanolic ammonia to give the acyclic nucleosides 21 and 23, respectively. The new nucleosides were inactive against HSV-1 and HIV-1.